| Literature DB >> 35531473 |
Abstract
To explore the possible mechanism of atipamezole in improving cognitive function after general anesthesia in aged rats, forty-five aged SD rats were separated into control, model, and atipamezole groups. Rats in the model group were anesthetized by intraperitoneal injection of 75 mg/kg ketamine plus 5 mg/kg midazolam. Results showed that the escape incubation period of the atipamezole group versus model group on the 2nd, 3rd, and 4th days was shortened, residence time of platform quadrant was prolonged on the 5th day, and number of times of crossing platform quadrant was increased. Compared with the control group, the residence time in the central region of the model group was shortened on the 1st, 2nd, and 3rd days. Atipamezole group's central residence time was prolonged on the 1st, 2nd, and 3rd days compared to the model group. Concentrations of IL-1, IL-6, and TNF-α in the hippocampus of the atipamezole group decreased significantly compared to the model group. The expressions of p-CREB and c-fos proteins in the prefrontal cortex and nucleus accumbens of rats in the atimezazole group were higher than those in the model group. In conclusion, atipamezole preconditioning can reduce cognitive dysfunction in aged rats after general anesthesia, and its mechanism may be related to inhibiting hippocampal inflammatory reaction and improving protein expression levels of p-CREB and c-fos in related brain regions of aged rats.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35531473 PMCID: PMC9068339 DOI: 10.1155/2022/7731333
Source DB: PubMed Journal: Dis Markers ISSN: 0278-0240 Impact factor: 3.464
Comparison of MWM results.
| Group |
| Escape incubation period (s) | Residence time in platform quadrant (s) | Number of times of crossing platform quadrant (frequency) | |||
|---|---|---|---|---|---|---|---|
| On the 1st day | On the 2nd day | On the 3rd day | On the 4th day | ||||
| Control group | 15 | 46.56 ± 3.51 | 34.57 ± 2.84 | 21.61 ± 1.93 | 14.58 ± 1.04 | 31.32 ± 3.47 | 14.25 ± 1.31 |
| Model group | 15 | 56.85 ± 4.69 | 45.08 ± 4.22a | 24.15 ± 2.84a | 19.43 ± 1.55a | 17.82 ± 2.63a | 6.14 ± 0.92a |
| Atipamezole group | 15 | 49.23 ± 3.04 | 37.95 ± 3.16b | 22.68 ± 1.45b | 15.19 ± 1.55b | 32.58 ± 3.06b | 15.03 ± 1.45b |
Compared with the control group, aP < 0.05; compared with the model group, bP < 0.05. The same below.
Comparison of residence time in central area.
| Group |
| On the 1st day | On the 2nd day | On the 3rd day |
|---|---|---|---|---|
| Control group | 15 | 70.75 ± 8.18 | 72.94 ± 9.32 | 68.53 ± 10.16 |
| Model group | 15 | 41.43 ± 6.05a | 36.37 ± 3.66a | 38.15 ± 5.47a |
| Atipamezole group | 15 | 75.58 ± 9.67b | 76.92 ± 8.41b | 69.81 ± 9.29b |
Comparison of serum markers in the hippocampus.
| Group |
| TNF- | IL-6 | IL-1 |
|---|---|---|---|---|
| Control group | 15 | 4.83 ± 0.32 | 3.04 ± 0.28 | 4.21 ± 0.41 |
| Model group | 15 | 9.57 ± 0.91a | 6.15 ± 0.43a | 11.87 ± 0.66a |
| Atipamezole group | 15 | 5.15 ± 0.26b | 4.78 ± 0.55b | 5.53 ± 0.37b |
Figure 1Comparison of expression levels of p-CREB and c-fos proteins in the hippocampus of rats in each group (n = 15).
Figure 2Comparison of expression levels of p-CREB and c-fos proteins in the prefrontal cortex of rats in each group (n = 15).
Figure 3Comparison of expression levels of p-CREB and c-fos proteins in nucleus accumbens of rats in each group (n = 15).